Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02518750
Title Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

lymphoma

acute lymphoblastic leukemia

Therapies

Bortezomib + Dexamethasone + Panobinostat

Pegaspargase

Mercaptopurine

Nelarabine

Mitoxantrone

Vincristine Sulfate

Cyclophosphamide + Etoposide

Cytarabine + Methotrexate + Prednisone

Clofarabine

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.